These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27320583)

  • 1. Influence of Angiotensin-converting Enzyme Genetic Polymorphism on Late Renal Dysfunction After Adult-to-adult Living-donor Liver Transplantation.
    Matsui T; Usui M; Fujinaga K; Nakatani K; Iizawa Y; Kato H; Tanemura A; Murata Y; Azumi Y; Kuriyama N; Kishiwada M; Mizuno S; Sakurai H; Isaji S
    Transplant Proc; 2016 May; 48(4):1184-9. PubMed ID: 27320583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and hepatitis C virus infection are strong risk factors for developing late renal dysfunction after living donor liver transplantation: significance of renal biopsy.
    Fujinaga K; Usui M; Yamamoto N; Ishikawa E; Nakatani A; Kishiwada M; Mizuno S; Sakurai H; Tabata M; Isaji S
    Transplant Proc; 2014 Apr; 46(3):804-10. PubMed ID: 24767353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients.
    Yildiz A; Yazici H; Cine N; Akkaya V; Kayacan SM; Sever MS; Erginel-Unaltuna N
    Clin Transplant; 2002 Jun; 16(3):173-9. PubMed ID: 12010139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic renal outcome after living donor liver transplantation.
    Nishi H; Shibagaki Y; Kido R; Tamura S; Nangaku M; Sugawara Y; Fujita T
    Clin Transplant; 2013; 27(1):90-7. PubMed ID: 22938398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme insertion/deletion polymorphism does not influence postcardiac transplantation hypertension onset or progression.
    Fildes JE; Walker AH; Densem CG; Deiraniya AK; Hutchinson IV; Leonard CT; Yonan N
    J Heart Lung Transplant; 2005 Apr; 24(4):406-10. PubMed ID: 15797740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function.
    Yagi S; Kaido T; Iida T; Yoshizawa A; Okajima H; Uemoto S
    Surg Today; 2017 Jun; 47(6):733-742. PubMed ID: 27837276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation.
    Fabris C; Toniutto P; Bitetto D; Minisini R; Fornasiere E; Smirne C; Pirisi M
    J Gastroenterol; 2007 Jul; 42(7):543-9. PubMed ID: 17653650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight gain after liver transplantation and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene.
    Toniutto P; Fabris C; Minisini R; Apollonio L; Fumo E; Caldato M; Smirne C; Pirisi M
    Transplantation; 2005 May; 79(10):1338-43. PubMed ID: 15912101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion insertion polymorphism of the angiotensin converting enzyme gene and progression of diabetic nephropathy.
    Björck S; Blohmé G; Sylvén C; Mulec H
    Nephrol Dial Transplant; 1997; 12 Suppl 2():67-70. PubMed ID: 9269704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
    Zivko M; Kusec R; Galesić K
    Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme gene polymorphism and development of post-transplant erythrocytosis.
    Yildiz A; Yazici H; Cine N; Kazancioglu R; Akkaya V; Sever MS; Ark E; Erginel-Unaltuna N
    J Nephrol; 2003; 16(3):399-403. PubMed ID: 12832741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ACE gene I/D polymorphism does not affect the susceptibility to or prognosis of PBC.
    Oruç N; Lamb J; Whitcomb DJ; Sass DA
    Turk J Gastroenterol; 2008 Dec; 19(4):250-3. PubMed ID: 19119484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme insertion/deletion polymorphism has no effect on the risk of atherosclerotic stroke or hypertension.
    Tascilar N; Dursun A; Ankarali H; Mungan G; Ekem S; Baris S
    J Neurol Sci; 2009 Oct; 285(1-2):137-41. PubMed ID: 19596363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?
    Broekroelofs J; Stegeman CA; Navis G; Tegzess AM; De Zeeuw D; De Jong PE
    J Am Soc Nephrol; 1998 Nov; 9(11):2075-81. PubMed ID: 9808093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA; Ascher NL; Freise CE; Dodge JL; Roberts JP
    Liver Transpl; 2012 Feb; 18(2):160-5. PubMed ID: 22006378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of I/D angiotensin-converting enzyme gene polymorphism in healthy subjects. Findings after follow-up of six years.
    Di Pasquale P; Cannizzaro S; Scalzo S; Maringhini G; Pipitone F; Fasullo S; Giubilato A; Ganci F; Vitale G; Sarullo FM; Paterna S
    Acta Cardiol; 2005 Aug; 60(4):427-35. PubMed ID: 16128377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of angiotensin-converting enzyme gene insertion/deletion polymorphism on rheumatic valve involvement, valve severity and subsequent valve calcification.
    Davutoglu V; Nacak M
    J Heart Valve Dis; 2005 May; 14(3):277-81. PubMed ID: 15974518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of renal function following bone marrow transplantation: an analysis of angiotensin converting enzyme D/I polymorphism and other clinical risk factors.
    Juckett MB; Cohen EP; Keever-Taylor CA; Zheng Y; Lawton CA; Moulder JE; Klein J
    Bone Marrow Transplant; 2001 Feb; 27(4):451-6. PubMed ID: 11313676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.